Related Experiment Video
Updated: Apr 26, 2026
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
The pathophysiology of transfusional iron overload
John B Porter1, Maciej Garbowski1
1Department of Haematology, University College London, 72 Huntley Street, London WC1E 6BT, UK.
Insights
Transfusional iron overload (TIO) causes organ damage and infection risk. Iron chelation therapy offers benefits, with iron distribution influenced by red cell breakdown and iron utilization by the erythron.
Area of Science:
- Hematology
- Toxicology
- Pharmacology
Background:
- Transfusional iron overload (TIO) is a complication of chronic blood transfusions.
- While well-studied in thalassemia major, TIO is increasingly recognized in other conditions.
- Excess iron accumulation impacts the heart, liver, and endocrine organs, leading to significant pathology.
Purpose of the Study:
- To describe the pathophysiologic consequences of TIO.
- To highlight the benefits of iron chelation therapy in managing TIO.
- To explore factors influencing iron distribution and toxicity outside the liver.
Main Methods:
- Review of existing literature on TIO and iron chelation therapy.
- Analysis of pathophysiologic mechanisms of iron toxicity.
- Discussion of iron metabolism and distribution dynamics.
Main Results:
- TIO leads to iron deposition in vital organs, causing damage.
- Iron overload increases susceptibility to infections due to labile iron availability.
- Extrahepatic iron distribution is influenced by the balance between iron generation and erythron utilization.
Conclusions:
- Understanding TIO pathophysiology is crucial for patient management.
- Iron chelation therapy is essential for mitigating TIO complications.
- Further research into iron distribution mechanisms can inform treatment strategies.
Abstract:
The pathophysiologic consequences of transfusional iron overload (TIO) as well as the benefits of iron chelation therapy are best described in thalassemia major, although TIO is increasingly seen in other clinical settings. These consequences broadly reflect the levels and distribution of excess storage iron in the heart, endocrine tissues, and liver. TIO also increases the risk of infection, due to increased availability of labile iron to microorganisms. The authors suggest that extrahepatic iron distribution, and hence toxicity, is influenced by balance between generation of nontransferrin-bound iron from red cell catabolism and the utilization of transferrin iron by the erythron.
Related Concept Videos
01:28The Early Endosome: Endocytosis of Transferrin
01:24Cirrhosis II: Pathophysiology
01:27Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
02:45Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:22Portal Hypertension
01:22Lifecycle of Erythrocytes
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....